Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Disseminated toxoplasmosis following T cell-depleted related and unrelated bone marrow transplantation.

Small TN, Leung L, Stiles J, Kiehn TE, Malak SA, O'Reilly RJ, Sepkowitz K.

Bone Marrow Transplant. 2000 May;25(9):969-73.

2.

Disseminated toxoplasmosis after bone marrow transplantation: report of 9 cases.

de Medeiros BC, de Medeiros CR, Werner B, Loddo G, Pasquini R, Bleggi-Torres LF.

Transpl Infect Dis. 2001 Mar;3(1):24-8. Review.

PMID:
11429036
3.

Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.

Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR.

Biol Blood Marrow Transplant. 2001;7(11):620-30.

4.

Toxoplasmosis in bone marrow-transplant recipients: report of seven cases and review.

Derouin F, Devergie A, Auber P, Gluckman E, Beauvais B, Garin YJ, Lariviere M.

Clin Infect Dis. 1992 Aug;15(2):267-70. Review.

PMID:
1520761
5.

T cell-depleted unrelated donor bone marrow transplantation for acute myeloid leukemia.

Marks DI, Bird JM, Vettenranta K, Hunt L, Green A, Cornish JM, Goulden N, Pamphilon DH, Steward CG, Oakhill A.

Biol Blood Marrow Transplant. 2000;6(6):646-53.

6.

Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions.

Small TN, Papadopoulos EB, Boulad F, Black P, Castro-Malaspina H, Childs BH, Collins N, Gillio A, George D, Jakubowski A, Heller G, Fazzari M, Kernan N, MacKinnon S, Szabolcs P, Young JW, O'Reilly RJ.

Blood. 1999 Jan 15;93(2):467-80.

8.

Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion.

Hahn T, Alam AR, Lawrence D, Ford L, Baer MR, Bambach B, Bernstein ZP, Czuczman MS, Silva J, Slack JL, Wetzler M, Becker J, McCarthy PL Jr.

Transplantation. 2004 Nov 27;78(10):1515-22.

PMID:
15599317
9.

Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation.

Alyea EP, Weller E, Fisher DC, Freedman AS, Gribben JG, Lee S, Schlossman RL, Stone RM, Friedberg J, DeAngelo D, Liney D, Windawi S, Ng A, Mauch P, Antin JH, Soiffer RJ.

Biol Blood Marrow Transplant. 2002;8(11):601-7.

PMID:
12463479
10.

Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience.

Slavin MA, Meyers JD, Remington JS, Hackman RC.

Bone Marrow Transplant. 1994 May;13(5):549-57.

PMID:
8054907
11.

Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.

Lee CK, deMagalhaes-Silverman M, Hohl RJ, Hayashi M, Buatti J, Wen BC, Schlueter A, Strauss RG, Gingrich RD.

Bone Marrow Transplant. 2003 Jan;31(2):121-8.

PMID:
12621494
12.

A prospective analysis of immune recovery in children following allogeneic transplantation of t-cell-depleted or non-T-cell-depleted hematopoietic cells from HLA-disparate family donors.

Kalwak K, Mosoń I, Cwian J, Gorczyńska E, Toporski J, Turkiewicz D, Latos-Grazyńska E, Chybicka A.

Transplant Proc. 2003 Jun;35(4):1551-5.

PMID:
12826218
13.

A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation.

Edvinsson B, Lundquist J, Ljungman P, Ringdén O, Evengård B.

APMIS. 2008 May;116(5):345-51. doi: 10.1111/j.1600-0463.2008.00871.x.

PMID:
18452424
14.

Diagnostic value of tests for Toxoplasma gondii-specific antibodies in patients undergoing bone marrow transplantation.

Janitschke K, Held T, Krüiger D, Schwerdtfeger R, Schlier G, Liesenfeld O.

Clin Lab. 2003;49(5-6):239-42.

PMID:
15285180
15.

Pulmonary toxoplasmosis in bone marrow transplant recipients: report of two cases and review.

Sing A, Leitritz L, Roggenkamp A, Kolb HJ, Szabados A, Fingerle V, Autenrieth IB, Heesemann J.

Clin Infect Dis. 1999 Aug;29(2):429-33. Review.

PMID:
10476754
16.

T-cell--depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect.

Alyea E, Weller E, Schlossman R, Canning C, Webb I, Doss D, Mauch P, Marcus K, Fisher D, Freeman A, Parikh B, Gribben J, Soiffer R, Ritz J, Anderson K.

Blood. 2001 Aug 15;98(4):934-9.

17.

CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.

Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Ball E, Cook D, Andresen S, Kuczkowski E, Bolwell B.

Bone Marrow Transplant. 2005 Feb;35(3):247-52.

PMID:
15580282
18.

T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.

Champlin RE, Passweg JR, Zhang MJ, Rowlings PA, Pelz CJ, Atkinson KA, Barrett AJ, Cahn JY, Drobyski WR, Gale RP, Goldman JM, Gratwohl A, Gordon-Smith EC, Henslee-Downey PJ, Herzig RH, Klein JP, Marmont AM, O'Reilly RJ, Ringdén O, Slavin S, Sobocinski KA, Speck B, Weiner RS, Horowitz MM.

Blood. 2000 Jun 15;95(12):3996-4003.

19.

T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.

Wang XN, Taylor PR, Skinner R, Jackson GH, Proctor SJ, Hedley D, Dickinson AM.

Transplantation. 2000 Aug 15;70(3):488-93.

PMID:
10949192
20.

Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantation.

Lynch BA, Vasef MA, Comito M, Gilman AL, Lee N, Ritchie J, Rumelhart S, Holida M, Goldman F.

Bone Marrow Transplant. 2003 Sep;32(5):527-33.

PMID:
12942101

Supplemental Content

Support Center